These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 10966178)

  • 1. Heparin-induced thrombocytopenia (HIT): in vitro and in vivo cross-reactivity to danaparoid sodium and successful treatment with recombinant hirudin (lepirudin).
    Baumgärtel MW; Eichler P; Glöckner WM; Ranze O; Greinacher A
    Eur J Haematol; 2000 Aug; 65(2):148-9. PubMed ID: 10966178
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of heparin-induced thrombocytopenia.
    Greinacher A
    Thromb Haemost; 1999 Aug; 82(2):457-67. PubMed ID: 10605737
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia].
    Chirurg; 1998 Nov; 69(11 Suppl Massnahme):1-4. PubMed ID: 9853175
    [No Abstract]   [Full Text] [Related]  

  • 4. Preventing complications in heparin-induced thrombocytopenia. Alternative anticoagulants are improving patient outcomes.
    Rice L; Nguyen PH; Vann AR
    Postgrad Med; 2002 Sep; 112(3):85-9. PubMed ID: 12360660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.
    Lubenow N; Greinacher A
    J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():47-57. PubMed ID: 11155194
    [No Abstract]   [Full Text] [Related]  

  • 6. Cross-Reactivity Between Heparin and Danaparoid Antibodies in Cardiac Surgery.
    Ronchard T; Salaun E; Theron A; Grisoli D; Jaussaud N; Collart F; Habib G; Camoin-Jau L
    Ann Thorac Surg; 2017 Jan; 103(1):e9-e10. PubMed ID: 28007287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-induced thrombocytopenia in paediatric patients--a review of the literature and a new case treated with danaparoid sodium.
    Ranze O; Ranze P; Magnani HN; Greinacher A
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S130-3. PubMed ID: 10650852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation with recombinant hirudin following bone marrow transplantation in a patient with activated protein C resistance and heparin-induced antibodies showing cross-reactivity to the heparinoid danaparoid.
    Sauer M; Gruhn B; Fuchs D; Altermann WW; Greinacher A; Völpel H; Zintl F
    Med Pediatr Oncol; 1999 Jun; 32(6):457-8. PubMed ID: 10358710
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparin-induced thrombocytopenia and its treatment.
    Warkentin TE
    J Thromb Thrombolysis; 2000 Jun; 9 Suppl 1():S29-35. PubMed ID: 10859582
    [No Abstract]   [Full Text] [Related]  

  • 10. [Heparin-induced thrombocytopenia].
    Depasse F; Samama MM
    Ann Biol Clin (Paris); 2000; 58(3):317-26. PubMed ID: 10846236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-induced thrombocytopenia: pathophysiology and management.
    Mureebe L; Silver D
    Vasc Endovascular Surg; 2002; 36(3):163-70. PubMed ID: 12075381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-induced thrombocytopenia: a ten-year retrospective.
    Warkentin TE
    Annu Rev Med; 1999; 50():129-47. PubMed ID: 10073268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lepirudin use in a neonate with heparin-induced thrombocytopenia.
    Nguyen TN; Gal P; Ransom JL; Carlos R
    Ann Pharmacother; 2003 Feb; 37(2):229-33. PubMed ID: 12549954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current agents for the treatment of patients with heparin-induced thrombocytopenia.
    Warkentin TE
    Curr Opin Pulm Med; 2002 Sep; 8(5):405-12. PubMed ID: 12172444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bounderies of the authorization to market and the therapeutic impass].
    Samama CM
    Ann Fr Anesth Reanim; 2001 Jun; 20(6):507-8. PubMed ID: 11471497
    [No Abstract]   [Full Text] [Related]  

  • 16. Heparin-induced thrombocytopenia: how to manage it, how to avoid it.
    Caiola E
    Cleve Clin J Med; 2000 Sep; 67(9):621-4. PubMed ID: 10992619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical cross-reactivity between danaparoid and heparin antibodies successfully managed with bivalirudin.
    Shapiro M; Cohen J; Inbal A; Singer P
    Isr Med Assoc J; 2009 Mar; 11(3):188-90. PubMed ID: 19544713
    [No Abstract]   [Full Text] [Related]  

  • 18. [Delayed hypersensitivity to heparins and heparinoids].
    Nicolie B; Bonneau JC; Le Sellin J; Gay G; Leclere JM; Drouet M
    Allerg Immunol (Paris); 2002 Feb; 34(2):47-50. PubMed ID: 11933754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro cross-reactivity of danaparoid sodium in patients with heparin-induced thrombocytopenia type II undergoing cardiovascular surgery.
    Koster A; Meyer O; Hausmann H; Kuppe H; Hetzer R; Mertzlufft F
    J Clin Anesth; 2000 Jun; 12(4):324-7. PubMed ID: 10960207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.